NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025

Core Insights - Nanobiotix, a late-stage clinical biotechnology company, is set to report its financial results for Q4 and the full year of 2024 on April 2, 2025, after the U.S. market closes [1] - A conference call and webcast will follow on April 3, 2025, at 8:00 AM EDT, where the CEO and CFO will discuss year-end results and business updates [2] Company Overview - Nanobiotix is headquartered in Paris, France, and has been listed on Euronext Paris since 2012 and on Nasdaq since December 2020 [5] - The company focuses on nanoparticle-based therapeutic approaches, particularly in oncology, bioavailability, and central nervous system disorders [5] - Nanobiotix holds over 25 patent families related to its three nanotechnology platforms [5]